Publications by the researcher in collaboration with SILVIA MARÍA SÁNCHEZ RAMÓN (10)

2012

  1. Autoanticuerpos en las enfermedades autoinmunes sistémicas

    Ergon

2010

  1. Interleucinas en la fisiopatología de la artritis reumatoide: más allá de las citocinas proinflamatorias

    Reumatologia Clinica, Vol. 6, Núm. SUPPL. 3

  2. Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy

    Rheumatology International, Vol. 30, Núm. 6, pp. 817-819

2009

  1. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 61, Núm. 4, pp. 419-424

  2. The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Do they imply new risk factors?

    Drug News and Perspectives, Vol. 22, Núm. 9, pp. 543-548

2006

  1. Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis

    Journal of Rheumatology, Vol. 33, Núm. 8, pp. 1476-1481

  2. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis

    Arthritis Care and Research, Vol. 55, Núm. 4, pp. 657-661

  3. Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy

    Lupus, Vol. 15, Núm. 12, pp. 881-885

2005

  1. Discordance between anti-β2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome

    Clinical and Experimental Rheumatology, Vol. 23, Núm. 4, pp. 525-528

  2. Prevalence of IgG anti-α-fodrin antibodies in Sjögren's syndrome

    Annals of the New York Academy of Sciences